|
1. Szponar L, Respondek W. [The role of nutrition in the development of circulatory system diseases] Wiad Lek. 1994 Oct;47(19-20):771-8. Review. Polish.
2. Sinatra ST, DeMarco J. Free radicals, oxidative stress, oxidized low density lipoprotein (LDL), and the heart: antioxidants and other strategies to limit cardiovascular damage. Conn Med. 1995 Oct;59(10):579-88.
3. Martyka Z, Kotela I, Blady-Kotela A. [Clinical use of magnesium] Przegl Lek. 1996;53(3):155-8. Review. Polish.
4. Grzegorczyk K, Rutkowski M, Drozda R. [Vitamin C in treatment of certain cardiovascular diseases] Pol Merkur Lekarski. 2001 Feb;10(56):122-5.
5. Rubio AR, Morales-Segura MA. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch Med Res. 2004 Jan-Feb;35(1):1-11.
6. Shaw CA, Taylor EL, Megson IL, Rossi AG. Nitric oxide and the resolution of inflammation: implications for atherosclerosis. Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:67-71.
7. Shaul PW. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J Physiol. 2003 Feb 15;547(Pt 1):21-33.
8. Takimoto E, Champion HC, Li M, Ren S, et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest. 2005 May;115(5):1221-31.
9. Aikawa K, Saitoh S, Muto M, et al. Effects of antioxidants on coronary microvascular spasm induced by epicardial coronary artery endothelial injury in pigs. Coron Artery Dis. 2004 Feb;15(1):21-30.
10. Angdin M, Settergren G, Starkopf J, Zilmer M, Zilmer K, Vaage J. Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003 Jun;17(3):314-20.
11. Meydani M. Dietary antioxidants modulation of aging and immune-endothelial cell interaction. Mech Aging Dev. 1999 Nov;111(2-3):123-32.
12. Schubert SY, Neeman I, Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J. 2002 Dec;16(14):1931-3.
13. Schulz E, Anter E, Keaney JF Jr. Oxidative stress, antioxidants, and endothelial function. Curr Med Chem. 2004 May;11(9):1093-104.
14. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 2001 Aug;38(2):274-9.
15. Rubio AR, Morales-Segura MA. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch Med Res. 2004 Jan-Feb;35(1):1-11.
16. Sugawara J, Komine H, Hayashi K, et al. Effect of systemic nitric oxide synthase inhibition on arterial stiffness in humans. Hypertens Res. 2007 May;30(5):411-5.
17. Mungall MM, Gaw A. Statin therapy in the elderly. Curr Opin Lipidol. 2004 Aug;15(4):453-7.
18. ten Dam VH, Box FM, de Craen AJ, et al; PROSPER Study Group. Lack of effect of pravastatin on cerebral blood flow or parenchymal volume loss in elderly at risk for vascular disease. Stroke. 2005 Aug;36(8):1633-6.
19. Weverling-Rijnsburger AW, Blauw GJ, Meinders AE. Effect of atorvastatin on impaired vascular function in healthy old men. J Clin Pharm Ther. 2004 Apr;29(2):157-64.
20. Hermann F, Spieker LE, Ruschitzka F, Sudano I, Hermann M, Binggeli C, Luscher TF, Riesen W, Noll G, Corti R. Dark chocolate improves endothelial and platelet function. Heart. 2006 Jan;92(1):119-20.
21. Sies H, Schewe T, Heiss C, et al. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr. 2005a Jan;81(1 Suppl):304S-312S.
22. Grassi D, Necozione S, Lippi C, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005a Aug;46(2):398-405.
23. Sies H, Stahl W, Sevanian A. Nutritional, dietary and postprandial oxidative stress. J Nutr. 2005b May;135(5):969-72.
24. Grassi D, Lippi C, Necozione S, et al. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr. 2005b Mar;81(3):611-614.
25. Mennen LI, Sapinho D, de Bree A, et al. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr. 2004;134:923–926.
26. Mursu J, Voutilainen S, Nurmi T, et al. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med. 2004;37:1351–1359.
27. Fraga CG, Actis-Goretta L, Ottaviani JI, et al. Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players. Clin Dev Immunol. 2005;12:11–17.
28. Baba S, Osakabe N, Kato Y, et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr. 2007 Mar;85(3):709-17.
29. Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004 Nov 10;292(18):2217-25.
30. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one-million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13.
31. Taubert D, Roesen R, Lehmann C, et al. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007 Jul 4;298(1):49-60.
32. Bremmer MA, Beekman AT, Deeg DJ, et al. Inflammatory markers in late-life depression: Results from a population-based study. J Affect Disord. 2007 Aug 21; [Epub ahead of print].
33. Cauley JA, Danielson ME, Boudreau RM, et al.; for the Health ABC Study. Inflammatory markers and incident fracture risk in older men and women: the health aging and body composition study. J Bone Miner Res. 2007 Jul;22(7):1088-95.
34. Csiszar A, Toth J, Peti-Peterdi J, et al. The aging kidney: role of endothelial oxidative stress and inflammation. Acta Physiol Hung. 2007 Mar;94(1-2):107-15.
35. Ferencik M, Stvrtinova V, Hulin I, et al. Inflammation—a lifelong companion. Attempt at a non-analytical holistic view. Folia Microbiol (Praha). 2007;52(2):159-73.
36. Lau FC, Shukitt-Hale B, Joseph JA. Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell Biochem. 2007;42:299-318.
37. Levick SP, Loch DC, Taylor SM, et al. Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol. 2007 Jan 15;178(2):641-6.
38. Leng SX, Xue QL, Tian J, et al. Inflammation and frailty in older women. J Am Geriatr Soc. 2007 Jun;55(6):864-71.
39. Matsuyama W, Mitsuyama H, Watanabe M, et al. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. Chest. 2005 Dec;128(6):3817-27.
40. Van Bodegom D, May L, Meij HJ, et al. Regulation of human life histories: the role of the inflammatory host response. Ann N Y Acad Sci. 2007 Apr;1100:84-97.
41. Schewe T, Sadik C, Klotz LO, et al. Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol Chem. 2001 Dec;382(12):1687-96.
42. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 1993;22 Suppl 4:S1-14. |